FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4241963591> ?p ?o ?g. }

• W4241963591 endingPage "S42" @default.
• W4241963591 startingPage "S42" @default.
• W4241963591 abstract "160 Using novel, mitogen-driven whole blood lymphocyte proliferation assays to quantitate drug effects in vivo, we show for the first time that PD, but not PK, predicts the relative in vivo immunosuppressive potencies of LFM and its analogs. Although that monitoring drug concentrations (PK) fails to predict immunosuppressive efficacy reliably, the utility of monitoring drug effects(PD) has not been previously shown. Our goal was to determine the relationships among dose, PK, PD and severity of histologic rejection in rat heart allograft recipients treated with LFM or MNAs. METHODS: Lewis rat recipients of BN heart grafts (n = 5/dose group) were treated daily for 21 d with doses of 1-15 mg/kg of oral LFM or its analogs 279, 715. Beginning on d 21, multiple blood samples were analyzed by HPLC to produce full PK profiles of A77 1726 ([A77], a MNA and the active metabolite of LFM), 279 and 715. The same blood samples were used for PD profiles by assessing levels of inhibition of ConA-driven whole blood lymphocyte proliferation ([3H] TdR). Drug effects were monitored by flow cytometry for inhibition of lymphocyte proliferation (% PCNA+ [proliferating cell nuclear antigen]/DNA+ cells) and inhibition of activation (%CD25+ [IL-2 R] and CD134+ [TNF R] cells). Following blood sampling, all grafts were removed and blindly scored for severity of histologic rejection. RESULTS: Plasma concentrations for each MNA correlated directly and significantly with PD measurements of lymphocyte function (A77: r2=0.77; 279: r2=0.77; 715: r2=0.81). These correlations followed an Emax model from which in vivo IC50's (mg/L) for inhibitions of lymphocyte proliferation were calculated: A77=0.8; 279=8.5; 715=36 demonstrating the wide range of in vivo potencies among the 3 MNAs which also predicted their relative potencies for inhibition of rejection(A77>279>715). Measurement of drug exposure (AUC) alone would not have predicted these differences in drug effects, since when the same dose (10 mg/kg) of each drug was administered to groups of rats, the exposure was much greater for 715 (895 mg.h/L) than 279 (412 mg.h/L) and A77 (130 mg.h/L). For each drug, severity of histologic rejection correlated inversely with its drug exposure and its inhibition of lymphocyte proliferation and activation. Administration of 2 mg/kg CsA or 5 mg/kg 279 showed no PD effects and failed to suppress rejection; coadministration did not alter PK but produced substantial PD effects and completely suppressed rejection. CONCLUSIONS: 1) PD, but not PK, predicted the relative in vivo immunosuppressive potencies of MNAs, 2) For each MNA, there was a significant correlation among dose, PK, PD and severity of rejection. 3) PD, but not PK, predicted the benefits of combined vs monotherapy with CsA and 279 demonstrating the value of PD for monitoring net immunosuppression. Funded by Hoechst-Marion-Roussel." @default.
• W4241963591 created "2022-05-12" @default.
• W4241963591 creator A5005712322 @default.
• W4241963591 creator A5038621452 @default.
• W4241963591 creator A5042068266 @default.
• W4241963591 creator A5051541912 @default.
• W4241963591 creator A5061778708 @default.
• W4241963591 creator A5071821787 @default.
• W4241963591 creator A5072118489 @default.
• W4241963591 creator A5076192025 @default.
• W4241963591 creator A5086551262 @default.
• W4241963591 creator A5088443683 @default.
• W4241963591 creator A5089205868 @default.
• W4241963591 date "1998-06-01" @default.
• W4241963591 modified "2023-09-28" @default.
• W4241963591 title "MONITORING OF PHARMACODYNAMICS (PD), BUT NOT PHARMACOKINETICS (PK), DIFFERENTIATES THE RELATIVE IMMUNOSUPPRESSIVE POTENCIES OF LEFLUNOMIDE AND ITS MALONONITRILAMIDE (MNA) ANALOGS" @default.
• W4241963591 doi "https://doi.org/10.1097/00007890-199806270-00179" @default.
• W4241963591 hasPublicationYear "1998" @default.
• W4241963591 type Work @default.
• W4241963591 citedByCount "3" @default.
• W4241963591 crossrefType "journal-article" @default.
• W4241963591 hasAuthorship W4241963591A5005712322 @default.
• W4241963591 hasAuthorship W4241963591A5038621452 @default.
• W4241963591 hasAuthorship W4241963591A5042068266 @default.
• W4241963591 hasAuthorship W4241963591A5051541912 @default.
• W4241963591 hasAuthorship W4241963591A5061778708 @default.
• W4241963591 hasAuthorship W4241963591A5071821787 @default.
• W4241963591 hasAuthorship W4241963591A5072118489 @default.
• W4241963591 hasAuthorship W4241963591A5076192025 @default.
• W4241963591 hasAuthorship W4241963591A5086551262 @default.
• W4241963591 hasAuthorship W4241963591A5088443683 @default.
• W4241963591 hasAuthorship W4241963591A5089205868 @default.
• W4241963591 hasBestOaLocation W42419635911 @default.
• W4241963591 hasConcept C111113717 @default.
• W4241963591 hasConcept C112705442 @default.
• W4241963591 hasConcept C126322002 @default.
• W4241963591 hasConcept C150903083 @default.
• W4241963591 hasConcept C1621761 @default.
• W4241963591 hasConcept C203014093 @default.
• W4241963591 hasConcept C207001950 @default.
• W4241963591 hasConcept C2777477808 @default.
• W4241963591 hasConcept C2777761686 @default.
• W4241963591 hasConcept C2778330430 @default.
• W4241963591 hasConcept C2780035454 @default.
• W4241963591 hasConcept C2780252810 @default.
• W4241963591 hasConcept C2911091166 @default.
• W4241963591 hasConcept C553184892 @default.
• W4241963591 hasConcept C71924100 @default.
• W4241963591 hasConcept C86803240 @default.
• W4241963591 hasConcept C98274493 @default.
• W4241963591 hasConceptScore W4241963591C111113717 @default.
• W4241963591 hasConceptScore W4241963591C112705442 @default.
• W4241963591 hasConceptScore W4241963591C126322002 @default.
• W4241963591 hasConceptScore W4241963591C150903083 @default.
• W4241963591 hasConceptScore W4241963591C1621761 @default.
• W4241963591 hasConceptScore W4241963591C203014093 @default.
• W4241963591 hasConceptScore W4241963591C207001950 @default.
• W4241963591 hasConceptScore W4241963591C2777477808 @default.
• W4241963591 hasConceptScore W4241963591C2777761686 @default.
• W4241963591 hasConceptScore W4241963591C2778330430 @default.
• W4241963591 hasConceptScore W4241963591C2780035454 @default.
• W4241963591 hasConceptScore W4241963591C2780252810 @default.
• W4241963591 hasConceptScore W4241963591C2911091166 @default.
• W4241963591 hasConceptScore W4241963591C553184892 @default.
• W4241963591 hasConceptScore W4241963591C71924100 @default.
• W4241963591 hasConceptScore W4241963591C86803240 @default.
• W4241963591 hasConceptScore W4241963591C98274493 @default.
• W4241963591 hasIssue "12" @default.
• W4241963591 hasLocation W42419635911 @default.
• W4241963591 hasLocation W42419635912 @default.
• W4241963591 hasOpenAccess W4241963591 @default.
• W4241963591 hasPrimaryLocation W42419635911 @default.
• W4241963591 hasRelatedWork W1893200055 @default.
• W4241963591 hasRelatedWork W1976890451 @default.
• W4241963591 hasRelatedWork W1978032370 @default.
• W4241963591 hasRelatedWork W1979757582 @default.
• W4241963591 hasRelatedWork W1998587742 @default.
• W4241963591 hasRelatedWork W2090099591 @default.
• W4241963591 hasRelatedWork W2227061539 @default.
• W4241963591 hasRelatedWork W2332367370 @default.
• W4241963591 hasRelatedWork W2957242515 @default.
• W4241963591 hasRelatedWork W1914240745 @default.
• W4241963591 hasVolume "65" @default.
• W4241963591 isParatext "false" @default.
• W4241963591 isRetracted "false" @default.
• W4241963591 workType "article" @default.